Trial
NCT04499352
A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Anal Canal Squamous Cell Carcinoma
Intervention
BI 754091
Why stopped
Not due to safety reasons (sponsor decision).
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-15